These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19846783)

  • 21. Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart.
    Lü S; Li Y; Gao S; Liu S; Wang H; He W; Zhou J; Liu Z; Zhang Y; Lin Q; Duan C; Yang XJ; Wang C
    J Cell Mol Med; 2010 Dec; 14(12):2771-9. PubMed ID: 20586830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fiber alignment and coculture with fibroblasts improves the differentiated phenotype of murine embryonic stem cell-derived cardiomyocytes for cardiac tissue engineering.
    Parrag IC; Zandstra PW; Woodhouse KA
    Biotechnol Bioeng; 2012 Mar; 109(3):813-22. PubMed ID: 22006660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.
    Caspi O; Huber I; Kehat I; Habib M; Arbel G; Gepstein A; Yankelson L; Aronson D; Beyar R; Gepstein L
    J Am Coll Cardiol; 2007 Nov; 50(19):1884-93. PubMed ID: 17980256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.
    Liao SY; Liu Y; Siu CW; Zhang Y; Lai WH; Au KW; Lee YK; Chan YC; Yip PM; Wu EX; Wu Y; Lau CP; Li RA; Tse HF
    Heart Rhythm; 2010 Dec; 7(12):1852-9. PubMed ID: 20833268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
    Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
    Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The electrophysiological development of cardiomyocytes.
    Liu J; Laksman Z; Backx PH
    Adv Drug Deliv Rev; 2016 Jan; 96():253-73. PubMed ID: 26788696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
    Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
    Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction.
    Liang J; Huang W; Jiang L; Paul C; Li X; Wang Y
    Stem Cells; 2019 Jul; 37(7):844-854. PubMed ID: 30913336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.
    Fassina D; Costa CM; Longobardi S; Karabelas E; Plank G; Harding SE; Niederer SA
    PLoS Comput Biol; 2022 Apr; 18(4):e1010030. PubMed ID: 35363778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes.
    Park J; Anderson CW; Sewanan LR; Kural MH; Huang Y; Luo J; Gui L; Riaz M; Lopez CA; Ng R; Das SK; Wang J; Niklason L; Campbell SG; Qyang Y
    Acta Biomater; 2020 Jan; 102():220-230. PubMed ID: 31634626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models.
    Yu Y; Qin N; Lu XA; Li J; Han X; Ni X; Ye L; Shen Z; Chen W; Zhao ZA; Lei W; Hu S
    Stem Cell Res Ther; 2019 Jun; 10(1):167. PubMed ID: 31196181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine.
    Roshanbinfar K; Esser TU; Engel FB
    Antioxid Redox Signal; 2021 Jul; 35(3):143-162. PubMed ID: 32993354
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
    Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
    Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies.
    Ng SY; Wong CK; Tsang SY
    Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1234-49. PubMed ID: 20844252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
    Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
    FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies.
    Gepstein L; Ding C; Rahmutula D; Wilson EE; Yankelson L; Caspi O; Gepstein A; Huber I; Olgin JE
    Stem Cells; 2010 Dec; 28(12):2151-61. PubMed ID: 20960511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
    Feric NT; Radisic M
    Adv Drug Deliv Rev; 2016 Jan; 96():110-34. PubMed ID: 25956564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered heart tissue model of diabetic myocardium.
    Song H; Zandstra PW; Radisic M
    Tissue Eng Part A; 2011 Jul; 17(13-14):1869-78. PubMed ID: 21417718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.